SCHEME 1. Retrosynthesis of HW-ketones
Synthesis of 7a-Substituted Hajos-Wiechert
Ketone Analogues
Jason W. J. Kennedy,† Sophia Vietrich, Hilmar Weinmann,
and Dominic E. A. Brittain*
Medicinal Chemistry, Bayer Schering Pharma AG,
13342 Berlin, Germany
chemists,5 and is a rare example of the catalytic formation of a
stereogenic quaternary carbon center.6 In view of this long
history and ongoing interest, it is surprising that very few
analogues have been reported where the angular substituent is
not a methyl group.7
ReceiVed March 20, 2008
These bicyclic diketones 1 are generally prepared via the
proline-catalyzed aldol cyclization of triketone 2, which in turn
comes from the Michael addition of cyclic 2-substituted 1,3-
dione 3 with methyl vinyl ketone 4 (Scheme 1). Key to this
process is the availability of the 2-substituted dione 3. Although
these substituted diones are very useful synthetic building blocks
for steroid and many other cyclopentanoid natural products,8
their preparation presents some significant challenges9 and their
availability is limited.10 Therefore, the first problem that needed
to be solved in the development of a route to HW-ketone
analogues was the establishment of a general route to 2-sub-
stituted 1,3-cyclopentadiones.
These diones are theoretically available by reaction of 1,3-
cyclopentadione 3b with electrophiles. However, yields for these
additions are generally quite low because the anion from 3b
preferentially undergoes O- rather than C-alkylation.8,11 While
a solution to this problem for 2-substituted 1,3-cyclohexadiones
was recently reported by Ramachary and Kishor in their
preparation of analogues of the Wieland-Miescher ketone,12
there remains no general synthetic approach to 2-substituted 1,3-
cyclopentadiones.
A general and efficient route to 2-substituted 1,3-cyclopen-
tadiones 3 has been developed. This operationally simple,
two-step procedure is amenable to multigram scale prepara-
tions of these useful synthetic intermediates. These com-
pounds are then transformed to previously unknown, higher
analogues of the Hajos-Parrish-Eder-Sauer-Wiechert
ketone (enone 1, R ) Me) following an enantioselective
Robinson annulation.
TheHajos-Parrish-Eder-Sauer-Wiechertketone1a(Scheme
1, R ) Me, henceforth referred to as the HW-ketone), first
reported independently by researchers at Schering AG1 and
Hoffmann La Roche Inc.2 over three decades ago, has found
extensive use in organic synthesis. This ketone is of biological
interest because it resembles the CD-ring system of steroids,
and is of synthetic interest because it can be prepared in
enantiomerically pure form from a remarkably simple organo-
catalyzed process.3 Consequently, it has been used as a chiral
building block in several syntheses.4 Furthermore, its synthesis
involves the first enantioselective aldol reaction developed by
Although simple alkylation of 1,3-cyclopentadione 3b is not
an effective reaction, an alternative approach starts with the
Knoevenagel addition of the dione to aldehydes (Figure 1).
However, this route is also not without its problems. The product
from these additions is the excellent Michael acceptor ene-dione
5, which, among other side reactions can then rapidly add a
(5) List, B.; Hoang, L.; Martin, H. J. Proc. Natl. Acad. Sci. 2004, 101, 5839–
5842.
(6) (a) Corey, E. J.; Guzman-Perez, A. Angew. Chem., Int. Ed. 1998, 37,
388–401. (b) Denissova, I.; Barriault, L. Tetrahedron 2003, 59, 10105–10146.
(7) For some notable exceptions, see refs 1 and 2, as well as the following: (a)
Smith, H.; Hughes, G. A.; Douglas, G. H.; Hartley, D.; McLoughlin, J.; Siddal,
J. B.; Wendt, G. R.; Buzby, G.C., Jr.; Herbst, D. R.; Ledig, K. W.; McMenamin,
J. R.; Pattison, T. W.; Suida, J.; Tokolics, J.; Edgren, R. A.; Jansen, A. B. A.;
Gadsby, B.; Watson, D. H. R.; Phillips, P. C. Experientia 1963, 19, 394–396.
(b) Blazejewski, J. C. J. Fluorine Chem. 1990, 46, 515–519. (c) Lacoste, E.;
Vaique, E.; Berlande, M.; Pianet, I.; Vincent, J.-M.; Landais, Y. Eur. J. Org.
Chem. 2007, 167–177.
† Current address: Bayer CropScience AG, IOP Industrialization, Geba¨ude
A729, 41538 Dormagen, Germany.
(1) Eder, U.; Sauer, G.; Wiechert, R. Angew. Chem., Int. Ed. Engl. 1971,
10, 496–497.
(2) Hajos, Z. G.; Parrish, D. R. J. Org. Chem. 1974, 39, 1615–1621.
(3) For a recent review, see Section 2.21 in: Mukherjee, S.; Yang, J. W.;
Hoffmann, S.; List, B. Chem. ReV. 2007, 107, 5471–5569.
(8) Schick, H.; Eichhorn, I. Synthesis 1989, 47, 7–492, and references cited
therein.
(4) Selected examples: (a) Paquette, L. A.; Wang, T.-Z.; Sivik, M. R. J. Am.
Chem. Soc. 1994, 116, 2665–2666. (b) Enev, V. S.; Petrov, O. S.; Neh, H.;
Nickisch, K. Tetrahedron 1997, 53, 13709–13718. (c) Overman, L. E.; Rucker,
P. V. Tetrahedron Lett. 1998, 39, 4643–4646. (d) Renneberg, D.; Pfander, H.;
Leumann, C. J. J. Org. Chem. 2000, 65, 9069–9079. (e) Molander, G. A.;
Quirmbach, M. S.; Silva, L.F., Jr.; Spencer, K. C.; Balsells, J. Org. Lett. 2001,
3, 2257–2260. (f) Lepage, O.; Stone, C.; Deslongchamps, P. Org. Lett. 2002, 4,
1091–1094. (g) Lugar, C. W., III; Magee, D.; Adrian, M. D.; Shetler, P.; Bryant,
H. U.; Dodge, J. A. Bioorg. Med. Chem. Lett. 2003, 13, 4281–4284. (h) Chochrek,
P.; Kurek-Tyrlik, A.; Michalak, K.; Wicha, J. Tetrahedron Lett. 2006, 47, 6017–
6020.
(9) For example, Beilstein only lists three syntheses for benzyl-type analogues
of 3, which are either not general or unsuitable for large-scale preparations: (a)
Hiraga, K. Chem. Pharm. Bull. 1965, 13, 1359–1361. (b) Tolstikov, G. A.;
Ismailov, S. A.; Velder, Ya. L.; Miftakhov, M. S. J. Org Chem. USSR (Engl.
Transl.) 1991, 27, 72–78. (c) Poss, A. J.; Belter, R. K. J. Org. Chem. 1988, 53,
891–891.
(10) The MDL Available Chemicals Directory reveals that only the methyl
and ethyl analogues of 3 are commercially available.
(11) McIntosh, J. M.; Beaumier, P. M. Can. J. Chem. 1973, 51, 843–847.
(12) Ramachary, D. B.; Kishor, M. J. Org. Chem. 2007, 72, 5056–5068.
10.1021/jo800638s CCC: $40.75
Published on Web 06/10/2008
2008 American Chemical Society
J. Org. Chem. 2008, 73, 5151–5154 5151